Fourth Catalyst for a Cure Tackles Neurodegeneration
Made possible by visionary donors, our latest research initiative targets the shared roots of conditions that occur when neurons deteriorate and die.
Menu
Menu
Made possible by visionary donors, our latest research initiative targets the shared roots of conditions that occur when neurons deteriorate and die.
The Catalyst for a Cure Initiative to Prevent and Cure Neurodegeneration will support creative collaboration by a team of four diversely talented young investigators.
What is neurodegeneration? And how will discoveries related to it affect people with glaucoma?
Dr. John G. Flanagan discusses recent discoveries that could cure glaucoma based on key research accomplishments from 20 years of Catalyst for a Cure.
Research paper summarizes the most important common elements that characterize progression in neurodegeneration and hope for new therapies to help patients with these devastating diseases.
This article summarizes published findings from Catalyst for a Cure (CFC1) research scientists and subsequent discoveries by Dr. Rebecca Sappington’s lab at Vanderbilt and Wake Forest.
The groundbreaking collaborative research program will explore common characteristics of glaucoma and Alzheimer’s.
Since 1980, the American Academy of Ophthalmology has presented a named lecture in honor of pioneering glaucoma specialist Robert N. Shaffer, MD in conjunction with their annual meeting.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2022 all rights reserved.
Print Subscription
(The printed edition of the Gleams newsletter is only available if you live in the United States or Canada)
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
E-mail Subscription
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.